Effects of Lactobacillus plantarum supplementation on glucose and lipid metabolism in type 2 diabetes mellitus and prediabetes: A systematic review and meta-analysis of randomized controlled trials.
- 2024-06
- Clinical nutrition ESPEN 61
- Hao Zhong
- Lingmiao Wang
- Fuhuai Jia
- Yongqiu Yan
- Feifei Xiong
- Yunhong Li
- Khemayanto Hidayat
- Rongfa Guan
- PubMed: 38777458
- DOI: 10.1016/j.clnesp.2024.04.009
Study Design
- Type
- Meta-Analysis
- Sample size
- n = 5
- Population
- patients with T2DM and prediabetes
- Methods
- systematic review and meta-analysis of RCTs; PubMed, Cochrane, and Web of Science databases searched; random-effects model used to estimate pooled mean difference with 95% CI
Research Insights
L. plantarum supplementation reduced the levels of fasting plasma glucose (-0.41, 95%CI -0.63, -0.19 mg/dL; n = 5)
- Effect
- Beneficial
- Effect size
- Small
A non-statistically significant tendency towards improvements in the Homeostatic Model Assessment for Insulin Resistance (MD: -0.74, 95%CI: -1.72, 0.25; n = 3)
- Effect
- Beneficial
- Effect size
- Small
A non-statistically significant tendency towards improvements in the Homeostatic Model Assessment for Insulin Resistance (MD: -0.74, 95%CI: -1.72, 0.25; n = 3)
- Effect
- Neutral
- Effect size
- Small
A non-statistically significant tendency towards improvements in high-density lipoprotein cholesterol (MD: 1.34; 95%CI: -0.78, 3.46 mg/dL; n = 3)
- Effect
- Neutral
- Effect size
- Small
high-density lipoprotein cholesterol (MD: 1.34; 95%CI: -0.78, 3.46 mg/dL; n = 3)
- Effect
- Beneficial
- Effect size
- Small
L. plantarum supplementation reduced the levels of hemoglobin A1c (-0.2, 95%CI: -0.3, 0%; n = 4)
- Effect
- Beneficial
- Effect size
- Small
low-density lipoprotein cholesterol (-6.87; 95%CI: -15.03, 1.29 mg/dL; n = 3)
- Effect
- Beneficial
- Effect size
- Small
A non-statistically significant tendency towards improvements in low-density lipoprotein cholesterol (-6.87; 95%CI: -15.03, 1.29 mg/dL; n = 3)
- Effect
- Neutral
- Effect size
- Small
A non-statistically significant tendency towards improvements in total cholesterol (MD: -4.88; 95%CI: -11.84, 2.07 mg/dL; n = 3)
- Effect
- Neutral
- Effect size
- Small
A non-statistically significant tendency towards improvements in triglyceride (MD: -3.90; 95%CI: -11.05, 3.24 mg/dL; n = 3)
- Effect
- Neutral
- Effect size
- Small